4//SEC Filing
Uger Robert 4
Accession 0001062993-21-004390
CIK 0001616212other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:24 PM ET
Size
8.5 KB
Accession
0001062993-21-004390
Insider Transaction Report
Form 4
Uger Robert
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Shares
2021-05-07$0.31/sh+3,646$1,141→ 3,646 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-07−3,646→ 109,375 totalExercise: $0.31Exp: 2029-11-07→ Common Shares (3,646 underlying) - Sale
Common Shares
2021-05-07$9.30/sh−3,646$33,908→ 0 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The exercise price of these options is $0.38 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.8237 USD.
- [F3]25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months.
Issuer
Trillium Therapeutics Inc.
CIK 0001616212
Entity typeother
Related Parties
1- filerCIK 0001838047
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:24 PM ET
- Size
- 8.5 KB